Pharmarise Holdings (TSE:2796) 3-Year EBITDA Growth Rate : 3.30% (As of Feb. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings 3-Year EBITDA Growth Rate?

Pharmarise Holdings's EBITDA per Share for the three months ended in Feb. 2024 was 円9.42.

During the past 12 months, Pharmarise Holdings's average EBITDA Per Share Growth Rate was -7.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 3.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 8.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Pharmarise Holdings was 40.00% per year. The lowest was -19.90% per year. And the median was 0.60% per year.

Competitive Comparison of Pharmarise Holdings's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmarise Holdings's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Pharmarise Holdings's 3-Year EBITDA Growth Rate falls into.

Pharmarise Holdings 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Pharmarise Holdings (TSE:2796) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Pharmarise Holdings 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmarise Holdings (TSE:2796) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011

Website

http://www.pharmarise.com

Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings (TSE:2796) Headlines

No Headlines